SHL Telemedicine Ltd. (NASDAQ:SHLT - Get Free Report) was the recipient of a large decline in short interest in the month of April. As of April 15th, there was short interest totalling 1,300 shares, a decline of 50.0% from the March 31st total of 2,600 shares. Based on an average daily trading volume, of 3,800 shares, the short-interest ratio is currently 0.3 days.
Wall Street Analyst Weigh In
Separately, Litchfield Hills Research reiterated a "buy" rating and set a $11.00 price target on shares of SHL Telemedicine in a research note on Thursday, March 14th.
Read Our Latest Report on SHL Telemedicine
SHL Telemedicine Stock Performance
NASDAQ:SHLT traded up $0.34 on Friday, reaching $5.55. 471 shares of the company's stock were exchanged, compared to its average volume of 3,766. The company has a quick ratio of 2.10, a current ratio of 2.30 and a debt-to-equity ratio of 0.20. The business has a fifty day moving average of $5.98 and a 200-day moving average of $7.61. SHL Telemedicine has a 52-week low of $4.86 and a 52-week high of $12.75.
SHL Telemedicine Company Profile
(
Get Free Report)
SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; Cardio'B, a portable device to transmit a 12-lead ECG; and Cardio Beeper 12/12, a hand-held ECG transmitter device for personal use that transmits a full ECG reading to the monitoring center.
Further Reading
Before you consider SHL Telemedicine, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SHL Telemedicine wasn't on the list.
While SHL Telemedicine currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
